NurExone Biologic Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 2, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	63	44	14	17	-
Market Cap Growth	45.63%	208.80%	-14.84%	-	-
Enterprise Value	61	41	13	12	-
Last Close Price	0.69	0.62	0.29	0.39	-
PB Ratio	30.85	17.35	57.03	5.89	-
P/TBV Ratio	30.85	17.35	57.03	5.89	-
Debt / Equity Ratio	0.05	0.02	6.44	0.01	0.89
Net Debt / Equity Ratio	-0.62	-0.38	3.58	-1.17	-0.99
Net Debt / EBITDA Ratio	0.14	0.14	-0.19	0.44	-
Net Debt / FCF Ratio	0.18	0.12	-0.22	0.63	0.95
Quick Ratio	1.28	2.08	0.34	4.17	1.67
Current Ratio	1.33	4.11	1.04	4.46	1.74
Return on Equity (ROE)	-298.06%	-517.23%	-318.51%	-499.17%	-
Return on Assets (ROA)	-129.23%	-135.79%	-92.09%	-123.02%	-
Return on Capital Employed (ROCE)	-362.80%	-245.20%	-1395.80%	-252.90%	-142.20%
Earnings Yield	-14.54%	-16.51%	-33.76%	-66.15%	-
FCF Yield	-11.49%	-18.13%	-28.40%	-31.58%	-
Buyback Yield / Dilution	-27.20%	-46.27%	-18.52%	-129.35%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.